Business Roundtable
Clinical Development Plan Diligence, Asset Valuation and the Fundamentals of Value Creation
Thursday, October 11, 2007
3:30 PM
Telegraph
This roundtable will discuss the following issues: ? Increasing CEO and investor awareness of the importance of early clinical development plan (CDP) optimization and asset valuation appropriate for development stage to inform investment decisions ? Common pitfalls of investment decision making in drug development and provide suggestions for avoiding pitfalls ? Real life examples of successful and failed decision making from both the investor and management (CEO) perspective, with emphasis on the factors driving success or failure
Moderators
- Russ Belden; Managing Partner, Bridge Consulting
Panelists
- Srinivas Akkaraju; Managing Director, Panorama Capital
- Ann McCarthy; Partner, Bridge Consulting
- Arlene Morris; Chief Executive Officer, Affymax
- Pratik Shah; Partner, Thomas, McNerney & Partners